Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase II/III Double Blinded, Randomized, Controlled, Non-inferiority Trial to Evaluate the Immunogenicity and Safety of Tri Fluvac, a Seasonal Trivalent Inactivated Split Virion Influenza Vaccine, in Healthy Thai Subjects Aged 18-49 Years

NCT03390166 is registered in ClinicalTrials.gov with Mahidol University as lead sponsor.

NCT NCT03390166
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03390166 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase II/III Double Blinded, Randomized, Controlled, Non-inferiority Trial to Evaluate the Immunogenicity and Safety of Tri Fluvac, a Seasonal Trivalent Inactivated Split Virion Influenza Vaccine, in Healthy Thai Subjects Aged 18-49 Years
Lead sponsor
Mahidol University
Phase
Phase 2/3
Overall status
Completed
Start date
July 24, 2017
Completion date
February 12, 2019
Enrollment
945 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

influenza